Firefly Neuroscience (AIFF): 10% owner sold ~$89K

~$89K

Approx. value · 30K sh @ $2.94

1.61M

Holds after · shares reported

Traded

Oct 9, 2025

Filed

Oct 14, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Aug 29, 2025Company filing · Form 8-K · Agreement ended, Executive changeChanged a top executive or board member, and ended an important agreement“On August 29, 2025, the Board of Directors (the “Board”) of the Company approved an amendment (the “Amendment”) to the employment agreement (the “Krzywicki Employment Agreement”), dated March 12, 2025, by and between Deel Canada Services Inc. (“Deel”), which provides consulting services to the Company, and Paul Krzywicki, the Chief Financial Officer of the Company.”
2. Oct 9, 2025 · this disclosureInsider10% owner sold ~$89K of AIFF shares in the open market

What came next

1. Oct 10, 2025Insider10% owner sold ~$202K of AIFF shares in the open market
2. Oct 13, 2025Insider10% owner sold ~$85K of AIFF shares in the open market
3. Oct 14, 2025Insider10% owner sold ~$81K of AIFF shares in the open market
4. Oct 15, 2025Insider10% owner sold ~$48K of AIFF shares in the open market
5. Oct 16, 2025Insider10% owner sold ~$106K of AIFF shares in the open market
6. Oct 17, 2025Insider10% owner sold ~$115K of AIFF shares in the open market
7. Oct 20, 2025Insider10% owner sold ~$82K of AIFF shares in the open market
8. Oct 21, 2025Insider10% owner sold ~$46K of AIFF shares in the open market
9. Oct 22, 2025Insider10% owner sold ~$162K of AIFF shares in the open market
10. Dec 16, 2025Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them
11. Feb 3, 2026Company filing · Form 8-K · Material agreement, Executive changeChanged a top executive or board member, and signed an important agreement“On February 4, 2026, Firefly Neuroscience Ltd., a wholly-owned subsidiary of the Company, entered into an addendum (the “Addendum”) to the Personal Employment Agreement dated February 2, 2017, and a Contract Addendum dated June 21, 2021 (collectively, the “Existing Employment Agreement”), with Gil Issachar, the Company's Chief Technology Officer.”

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Firefly Neuroscience

OQRO holds no insider, Congress, fund or contract record for Firefly Neuroscience dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its AIFF page.

Other recent filings by Windsor Private Capital LP, 10% owner

• SEC Form 4 at Firefly Neuroscience (AIFF)Oct 22, 2025
• SEC Form 4 at Firefly Neuroscience (AIFF)Oct 22, 2025
• SEC Form 4 at Firefly Neuroscience (AIFF)Oct 22, 2025
• SEC Form 4 at Firefly Neuroscience (AIFF)Oct 18, 2025
• SEC Form 4 at Firefly Neuroscience (AIFF)Oct 18, 2025

The full history of Windsor Private Capital LP, 10% owner is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Firefly Neuroscience

• SEC Form 4Oct 22, 2025
• SEC Form 4Oct 22, 2025
• SEC Form 4Oct 22, 2025
• SEC Form 4Oct 18, 2025
• SEC Form 4Oct 18, 2025
• SEC Form 4Oct 18, 2025

Everything OQRO holds on this company is on its AIFF page.